US Stock MarketDetailed Quotes

REVB Revelation Biosciences

Watchlist
  • 0.2950
  • -0.0196-6.23%
Close Dec 20 16:00 ET
  • 0.3005
  • +0.0055+1.86%
Post 20:01 ET
1.91MMarket Cap-0.02P/E (TTM)

Revelation Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-35.32%1.8M
30.49%2.52M
17.43%1.9M
-20.32%8.66M
90.91%2.33M
131.59%2.78M
3.90%1.93M
-75.41%1.62M
-9.09%10.86M
-68.41%1.22M
Selling and administrative expenses
-14.28%965.71K
10.13%1.13M
8.22%1.18M
-17.79%4.51M
44.12%1.27M
37.73%1.13M
15.70%1.02M
-62.33%1.09M
8.96%5.49M
-26.28%878.36K
-General and administrative expense
-14.28%965.71K
10.13%1.13M
8.22%1.18M
-17.79%4.51M
44.12%1.27M
37.73%1.13M
15.70%1.02M
-62.33%1.09M
8.96%5.49M
-26.28%878.36K
Research and development costs
-49.68%830.98K
53.41%1.39M
36.61%717.58K
-22.90%4.15M
211.79%1.06M
332.79%1.65M
-6.80%909.28K
-85.73%525.27K
-22.23%5.38M
-87.25%339.97K
Operating profit
35.32%-1.8M
-30.49%-2.52M
-17.43%-1.9M
20.32%-8.66M
-90.91%-2.33M
-131.59%-2.78M
-3.90%-1.93M
75.41%-1.62M
9.09%-10.86M
68.41%-1.22M
Net non-operating interest income expense
Other net income (expense)
-397.54%-444.88K
-1,310.13%-5.87M
-110.02%-779.3K
24,316.25%8.54M
122.99K
149.52K
1,784.12%484.86K
25,823.49%7.78M
196.18%34.96K
Gain on sale of security
-93.47%6.04K
-98.96%4.42K
-99.12%68.43K
--8.33M
--68.2K
--92.56K
--423.24K
--7.74M
----
----
Other non- operating income (expenses)
-891.64%-450.92K
-9,628.96%-5.87M
-2,585.48%-847.72K
493.42%207.47K
--54.79K
--56.96K
139.45%61.62K
212.78%34.11K
196.18%34.96K
----
Income before tax
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
Income tax
Net income
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
Net income continuous Operations
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
Minority interest income
Net income attributable to the parent company
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
98.89%-120.25K
-82.42%-2.2M
-124.51%-2.63M
21.07%-1.45M
193.09%6.16M
9.65%-10.83M
68.72%-1.21M
Basic earnings per share
91.55%-0.84
12.01%-5.13
-105.40%-2.46
99.64%-0.53
80.87%-10.15
82.65%-9.94
95.33%-5.83
109.54%45.52
84.66%-149.2
83.06%-53.0527
Diluted earnings per share
91.55%-0.84
12.01%-5.13
-106.64%-2.46
99.64%-0.53
80.87%-10.15
82.65%-9.94
95.33%-5.83
107.77%37.07
84.66%-149.2
83.06%-53.0527
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -35.32%1.8M30.49%2.52M17.43%1.9M-20.32%8.66M90.91%2.33M131.59%2.78M3.90%1.93M-75.41%1.62M-9.09%10.86M-68.41%1.22M
Selling and administrative expenses -14.28%965.71K10.13%1.13M8.22%1.18M-17.79%4.51M44.12%1.27M37.73%1.13M15.70%1.02M-62.33%1.09M8.96%5.49M-26.28%878.36K
-General and administrative expense -14.28%965.71K10.13%1.13M8.22%1.18M-17.79%4.51M44.12%1.27M37.73%1.13M15.70%1.02M-62.33%1.09M8.96%5.49M-26.28%878.36K
Research and development costs -49.68%830.98K53.41%1.39M36.61%717.58K-22.90%4.15M211.79%1.06M332.79%1.65M-6.80%909.28K-85.73%525.27K-22.23%5.38M-87.25%339.97K
Operating profit 35.32%-1.8M-30.49%-2.52M-17.43%-1.9M20.32%-8.66M-90.91%-2.33M-131.59%-2.78M-3.90%-1.93M75.41%-1.62M9.09%-10.86M68.41%-1.22M
Net non-operating interest income expense
Other net income (expense) -397.54%-444.88K-1,310.13%-5.87M-110.02%-779.3K24,316.25%8.54M122.99K149.52K1,784.12%484.86K25,823.49%7.78M196.18%34.96K
Gain on sale of security -93.47%6.04K-98.96%4.42K-99.12%68.43K--8.33M--68.2K--92.56K--423.24K--7.74M--------
Other non- operating income (expenses) -891.64%-450.92K-9,628.96%-5.87M-2,585.48%-847.72K493.42%207.47K--54.79K--56.96K139.45%61.62K212.78%34.11K196.18%34.96K----
Income before tax 14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M
Income tax
Net income 14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M
Net income continuous Operations 14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M
Minority interest income
Net income attributable to the parent company 14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.72%-2.24M-479.34%-8.39M-143.54%-2.68M98.89%-120.25K-82.42%-2.2M-124.51%-2.63M21.07%-1.45M193.09%6.16M9.65%-10.83M68.72%-1.21M
Basic earnings per share 91.55%-0.8412.01%-5.13-105.40%-2.4699.64%-0.5380.87%-10.1582.65%-9.9495.33%-5.83109.54%45.5284.66%-149.283.06%-53.0527
Diluted earnings per share 91.55%-0.8412.01%-5.13-106.64%-2.4699.64%-0.5380.87%-10.1582.65%-9.9495.33%-5.83107.77%37.0784.66%-149.283.06%-53.0527
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+6.16%
DexCom
DXCM
+5.57%
New Fortress Energy
NFE
+5.37%
Workday
WDAY
+2.33%
eBay
EBAY
+1.66%

Unlock the Full List